This inventor holds 1 USPTO granted patent. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Philip P. Miner, Jr.
Introduction
Philip P. Miner, Jr. is an accomplished inventor based in Oklahoma City, OK. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pouchitis. His innovative approach has led to the development of a unique method that utilizes antisense oligonucleotides.
Latest Patents
Miner holds a patent for "Compositions and methods for treatment of pouchitis." This invention focuses on administering a pharmaceutical formulation suitable for rectal use, such as an enema or suppository, which comprises an antisense oligonucleotide targeted to ICAM-1. This method aims to provide effective treatment options for individuals suffering from this condition.
Career Highlights
Miner is associated with Isis Pharmaceuticals, Inc., where he has been able to apply his expertise in developing groundbreaking treatments. His work has been instrumental in advancing the understanding and management of pouchitis, showcasing his dedication to improving patient outcomes.
Collaborations
Miner has collaborated with notable professionals in his field, including his coworker Mark K. Wedel. Their combined efforts have contributed to the success of their projects and the advancement of medical treatments.
Conclusion
Philip P. Miner, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of pouchitis, highlight the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile